# A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants

> **NCT06068855** · PHASE3 · COMPLETED · sponsor: **AbbVie** · enrollment: 249 (actual)

## Conditions studied

- Masseter Muscle Prominence

## Interventions

- **DRUG:** BOTOX
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06068855
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-17
- **Primary completion:** 2025-11-20
- **Final completion:** 2025-11-20
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06068855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06068855, "A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06068855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*